Stockreport

Immuneering to Present at the Leerink Global Healthcare Conference

Immuneering Corporation - Class A  (IMRX) 
PDF NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive an [Read more]